Development of A4 antibody for detection of neuraminidase I223R/H275Y-associated antiviral multidrug-resistant influenza virus

Kyeonghye Guk; Hyeran Kim; Miyeon Lee; Yoon Aa Choi; Seul Gee Hwang; Gaon Han; Hye Nan Kim; Hongki Kim; Hwangseo Park; Dongeun Yong; Taejoon Kang; Eun Kyung Lim; Juyeon Jung

doi:10.1038/s41467-020-17246-w

Development of A4 antibody for detection of neuraminidase I223R/H275Y-associated antiviral multidrug-resistant influenza virus

Kyeonghye Guk, Hyeran Kim, Miyeon Lee, Yoon Aa Choi, Seul Gee Hwang, Gaon Han, Hye Nan Kim, Hongki Kim, Hwangseo Park, Dongeun Yong, Taejoon Kang, Eun Kyung Lim, Juyeon Jung

Department of Laboratory Medicine

Research output: Contribution to journal › Article › peer-review

9 Citations (Scopus)

Abstract

The emergence and spread of antiviral drug-resistant viruses have been a worldwide challenge and a great concern for patient care. We report A4 antibody specifically recognizing and binding to the mutant I223R/H275Y neuraminidase and prove the applicability of A4 antibody for direct detection of antiviral multidrug-resistant viruses in various sensing platforms, including naked-eye detection, surface-enhanced Raman scattering-based immunoassay, and lateral flow system. The development of the A4 antibody enables fast, simple, and reliable point-of-care assays of antiviral multidrug-resistant influenza viruses. In addition to current influenza virus infection testing methods that do not provide information on the antiviral drug-resistance of the virus, diagnostic tests for antiviral multidrug-resistant viruses will improve clinical judgment in the treatment of influenza virus infections, avoid the unnecessary prescription of ineffective drugs, and improve current therapies.

Original language	English
Article number	3418
Journal	Nature communications
Volume	11
Issue number	1
DOIs	https://doi.org/10.1038/s41467-020-17246-w
Publication status	Published - 2020 Dec 1

Bibliographical note

Funding Information:
This research was supported by the Center for BioNano Health-Guard funded by the Ministry of Science and ICT (MSIT) of Korea as Global Frontier Project (HGUARD_2013M3A6B2078950 and HGUARD_2014M3A6B2060507), the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by MSIT of Korea (NRF-2018M3A9E2022821), the Basic Science Research Program of the NRF funded by MSIT of Korea (NRF-2018R1C1B6005424, NRF-2020R1A2C1010453 and NRF2019R1C1C1006867), and KRIBB Initiative Research Program.

Publisher Copyright:
© 2020, The Author(s).

All Science Journal Classification (ASJC) codes

Chemistry(all)
Biochemistry, Genetics and Molecular Biology(all)
Physics and Astronomy(all)

Access to Document

10.1038/s41467-020-17246-w

Cite this

@article{60133bb9c73a4dc8bcb3e5719cbd44ab,

title = "Development of A4 antibody for detection of neuraminidase I223R/H275Y-associated antiviral multidrug-resistant influenza virus",

abstract = "The emergence and spread of antiviral drug-resistant viruses have been a worldwide challenge and a great concern for patient care. We report A4 antibody specifically recognizing and binding to the mutant I223R/H275Y neuraminidase and prove the applicability of A4 antibody for direct detection of antiviral multidrug-resistant viruses in various sensing platforms, including naked-eye detection, surface-enhanced Raman scattering-based immunoassay, and lateral flow system. The development of the A4 antibody enables fast, simple, and reliable point-of-care assays of antiviral multidrug-resistant influenza viruses. In addition to current influenza virus infection testing methods that do not provide information on the antiviral drug-resistance of the virus, diagnostic tests for antiviral multidrug-resistant viruses will improve clinical judgment in the treatment of influenza virus infections, avoid the unnecessary prescription of ineffective drugs, and improve current therapies.",

author = "Kyeonghye Guk and Hyeran Kim and Miyeon Lee and Choi, {Yoon Aa} and Hwang, {Seul Gee} and Gaon Han and Kim, {Hye Nan} and Hongki Kim and Hwangseo Park and Dongeun Yong and Taejoon Kang and Lim, {Eun Kyung} and Juyeon Jung",

note = "Funding Information: This research was supported by the Center for BioNano Health-Guard funded by the Ministry of Science and ICT (MSIT) of Korea as Global Frontier Project (HGUARD_2013M3A6B2078950 and HGUARD_2014M3A6B2060507), the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by MSIT of Korea (NRF-2018M3A9E2022821), the Basic Science Research Program of the NRF funded by MSIT of Korea (NRF-2018R1C1B6005424, NRF-2020R1A2C1010453 and NRF2019R1C1C1006867), and KRIBB Initiative Research Program. Publisher Copyright: {\textcopyright} 2020, The Author(s).",

year = "2020",

month = dec,

day = "1",

doi = "10.1038/s41467-020-17246-w",

language = "English",

volume = "11",

journal = "Nature Communications",

issn = "2041-1723",

publisher = "Nature Publishing Group",

number = "1",

}

TY - JOUR

T1 - Development of A4 antibody for detection of neuraminidase I223R/H275Y-associated antiviral multidrug-resistant influenza virus

AU - Guk, Kyeonghye

AU - Kim, Hyeran

AU - Lee, Miyeon

AU - Choi, Yoon Aa

AU - Hwang, Seul Gee

AU - Han, Gaon

AU - Kim, Hye Nan

AU - Kim, Hongki

AU - Park, Hwangseo

AU - Yong, Dongeun

AU - Kang, Taejoon

AU - Lim, Eun Kyung

AU - Jung, Juyeon

N1 - Funding Information: This research was supported by the Center for BioNano Health-Guard funded by the Ministry of Science and ICT (MSIT) of Korea as Global Frontier Project (HGUARD_2013M3A6B2078950 and HGUARD_2014M3A6B2060507), the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by MSIT of Korea (NRF-2018M3A9E2022821), the Basic Science Research Program of the NRF funded by MSIT of Korea (NRF-2018R1C1B6005424, NRF-2020R1A2C1010453 and NRF2019R1C1C1006867), and KRIBB Initiative Research Program. Publisher Copyright: © 2020, The Author(s).

PY - 2020/12/1

Y1 - 2020/12/1

N2 - The emergence and spread of antiviral drug-resistant viruses have been a worldwide challenge and a great concern for patient care. We report A4 antibody specifically recognizing and binding to the mutant I223R/H275Y neuraminidase and prove the applicability of A4 antibody for direct detection of antiviral multidrug-resistant viruses in various sensing platforms, including naked-eye detection, surface-enhanced Raman scattering-based immunoassay, and lateral flow system. The development of the A4 antibody enables fast, simple, and reliable point-of-care assays of antiviral multidrug-resistant influenza viruses. In addition to current influenza virus infection testing methods that do not provide information on the antiviral drug-resistance of the virus, diagnostic tests for antiviral multidrug-resistant viruses will improve clinical judgment in the treatment of influenza virus infections, avoid the unnecessary prescription of ineffective drugs, and improve current therapies.

AB - The emergence and spread of antiviral drug-resistant viruses have been a worldwide challenge and a great concern for patient care. We report A4 antibody specifically recognizing and binding to the mutant I223R/H275Y neuraminidase and prove the applicability of A4 antibody for direct detection of antiviral multidrug-resistant viruses in various sensing platforms, including naked-eye detection, surface-enhanced Raman scattering-based immunoassay, and lateral flow system. The development of the A4 antibody enables fast, simple, and reliable point-of-care assays of antiviral multidrug-resistant influenza viruses. In addition to current influenza virus infection testing methods that do not provide information on the antiviral drug-resistance of the virus, diagnostic tests for antiviral multidrug-resistant viruses will improve clinical judgment in the treatment of influenza virus infections, avoid the unnecessary prescription of ineffective drugs, and improve current therapies.

UR - http://www.scopus.com/inward/record.url?scp=85087693005&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85087693005&partnerID=8YFLogxK

U2 - 10.1038/s41467-020-17246-w

DO - 10.1038/s41467-020-17246-w

M3 - Article

C2 - 32647286

AN - SCOPUS:85087693005

SN - 2041-1723

VL - 11

JO - Nature Communications

JF - Nature Communications

IS - 1

M1 - 3418

ER -

Development of A4 antibody for detection of neuraminidase I223R/H275Y-associated antiviral multidrug-resistant influenza virus

Abstract

Bibliographical note

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this